Nonalcoholic Fatty Liver Disease

McCarthy, E. (2014). Nonalcoholic fatty liver disease. Today's Dietitian. 16(1) 48. http://www.todaysdietitian.com/newarchives/010614p48.shtml

          Nonalcoholic fatty liver disease is the most common liver disease in the United States. It is

characterized by the accumulation of triglycerides in in liver cells of people who do not abuse

alcohol. There are various levels of nonalcoholic fatty liver disease, ranging from fat accumulation

and inflammation, to cirrhosis and liver failure, to eventual kidney failure, heart failure, and death.

          A majority of obese people in the United States (80-90% estimated) also have NAFLD and

36% of these have an aggressive form of NAFLD. A high BMI does not necessarily mean fatty liver

disease. There have been more and more cases recently with NAFLD patients who have a normal

BMI, but do have central adiposity and insulin resistance. This suggests a direct correlation between

hepatic fat content and visceral adiposity. Diet has a lot to do with this. High total fat intake, high

saturated fat intake, high trans fatty intake, and high processed carbohydrate have all been associated

with an increased risk of NAFLD.

          No specific medications have been approved to treat NAFLD. The current standard of care

focuses on lifestyle interventions such as diet and exercise. Sustained weight loss has been the most

effective treatment of NAFLD and should be the main goal of any treatment plan. A weight loss as

little as 5-10% has shown significant improvement in inflammation. It is important to monitor dietary

intake and physical activity of the patient, but also educate their family members to ensure a good

support system and a higher rate of success.

-DU

Comments

  1. Research participants needed for a pharmaceutical research study to test an investigational drug for obesity. We are looking for overweight males and females eighteen years or older including those who may have type ii diabetes or have been told that they have fatty liver. Participants must be available for ten outpatient clinic visits over a period of approximately 5 months.
    Enrolled participants will be compensated for time and participation.
    For more information call seaview research at three zero five, six four six, six seven eight five https://studyscavengerapp.com/quotient-sciences-paid-clinical-trial-investigate-efficacy-lik066-obese-patients-volunteers-non-alcoholic-steatohepatitis-fatty-liver-disease-miami-fl/

    #miami #broward #nafld

    ReplyDelete

Post a Comment

Popular posts from this blog

Do you struggle with pre and post exercise nutrition?

Child Malnutrition

Harvest of the Month